Reimbursement
Touting the benefits of the Affordable Care Act to cover Americans who otherwise would not have healthcare plans, the Centers for Medicare and Medicaid Services on Tuesday said the median deductible for marketplace coverage in 2016 is $850, down from $900 in 2015.
More than half of hospitals are not currently using revenue cycle vendors claims denials management tools, according to a new survey from Healthcare IT News sister company HIMSS Analytics, and that reality presents a large opportunity for providers to get more expedient payment.
Oregon's Health Co-op went into state receivership by court petition on Monday, according to the Oregon Department of Consumer and Business Services, Division of Financial Regulation.
High-need individuals who cost the public or private sectors $50,000 or more in a single year top the list of the most expensive sources of healthcare costs, according to a study released by the American Health Policy Institute.
The federal government's risk adjustment mandate has added another financially struggling consumer oriented and operated plan to the growing list of failed government co-op's established under the Affordable Care Act.
Parents who say their children with autism are legally entitled to applied behavioral analysis -- or ABA -- treatment are butting heads with Texas officials. And without Medicaid coverage, they must either forgo the therapy or find a way to pay for individual insurance plans that help pick up the costs.
New research published Wednesday found that states that legalized medical marijuana -- which is sometimes recommended for symptoms like chronic pain, anxiety or depression -- saw declines in the number of Medicare prescriptions for drugs used to treat those conditions and a dip in spending by Medicare Part D, which covers the cost on prescription medications.
Proposal would eliminate any potential financial pressure clinicians may feel to over-prescribe pain medications, especially opioids.
A new study takes a fresh measure of generic drugs' price advantages, revealing how much more Medicare Part D patients shelled out in copayments for two popular brand-name drugs in 2013. The result: 10.5 times more.
HHS said consumers could buy fixed indemnity insurance thinking they were getting comprehensive coverage.